Tag Archives: Risperdal

Featured Stories

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Transvaginal Mesh Lawsuit Trial

$5.5 Million Awarded to Plaintiffs in First Transvaginal Mesh Lawsuit Trial

An award of $5.5 million has been made in the first trial over a transvaginal mesh lawsuit. The jury found against medical device maker, C.R. Bard, and its Avaulta Plus transvaginal mesh. The jury agreed that Bard’s Avaulta Plus transvaginal mesh caused numerous and painful injuries in a California woman. ...

Read More

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...

Read More

Medtronic Settles Charges Over Kickbacks To Doctors

Medical device giant, Medtronic Inc., is settling charges over kickbacks to doctors. The firms just agreed to pay $23.5 million to settle claims it paid physicians kickbacks in exchange for their use of its pacemakers and defibrillators, according to a U.S. Justice Department announcement yesterday. The company was accused of seeking ...

Read More

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Risperdal Litigation is Second Largest Mass Tort in Philadelphia

Risperdal Litigation is Second Largest Mass Tort in PA

Mass Tort Contains Risperdal Gynecomastia Lawsuits Lawsuits alleging the antipsychotic drug Risperdal caused gynecomastia continue to mount against Johnson & Johnson’s Janssen unit. In fact, Risperdal litigation accounts for most of the mass tort growth in Philadelphia’s Complex Litigation Center. … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Jurors Told that J&J Obscured Risperdal Gynecomastia Data

Jurors Told that J&J Obscured Risperdal Gynecomastia Data

A number of lawsuits have been filed over Risperdal, an antipsychotic medication marketed by Johnson & Johnson’s Janssen Pharmaceuticals. Plaintiffs allege that the drug caused gynecomastia, or abnormal breast growth, in adolescent boys. The suits allege that J&J knew about … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , |

$70 Million Awarded in Risperdal Gynecomastia Lawsuit

$70 Million Awarded in Risperdal Gynecomastia Lawsuit

An attempt was made by Johnson & Johnson (J&J) to overturn the largest award seen to date in a $70 million Risperdal gynecomastia verdict. The Pennsylvania judge presiding over the matter refused the request made by the manufacturer of J&J’s … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , , , , , , , , , |

Judge Pauses Philadelphia Risperdal Trial in Data Analysis Dispute

Judge Pauses Philadelphia Risperdal Trial in Data Dispute

Judge Kenneth Powell of the Philadelphia Court of Common Pleas has paused a trial over an adolescent boy’s breast growth allegedly caused by the antipsychotic drug Risperdal (risperidone) so that the drug maker can turn over more evidence for the … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals | Tagged , , , , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.